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The chromosome passenger complex (CPC) must
relocate from anaphase chromosomes to the cell
equator for successful cytokinesis. Although this
landmark event requires the mitotic kinesin MKlp2,
the spatiotemporal mechanistic basis remains
elusive. Here, we show that phosphoregulation of
MKlp2 by the mitotic kinase Cdk1/cyclin B1 coordi-
nates proper mitotic transition with CPC relocation.
We identified multiple Cdk1/cyclin B1 phosphoryla-
tion sites within the stalk and C-terminal tail that
inhibit microtubule binding and bundling, oligo-
merization/clustering, and chromosome targeting
of MKlp2. Specifically, inhibition of these abilities
by Cdk1/cyclin B1 phosphorylation is essential for
proper early mitotic progression. Upon anaphase
onset, however, reversal of Cdk1/cyclin B1 phos-
phorylation promotes MKlp2-CPC complex forma-
tion and relocates the CPC from anaphase chromo-
somes for successful cytokinesis. Thus, we propose
that phosphoregulation of MKlp2 by Cdk1/cyclin
B1 ensures that activation of MKlp2 kinesin and relo-
cation of the CPC occur at the appropriate time and
space for proper mitotic progression and genomic
stability.
INTRODUCTION
For successful cell division, faithful segregation of duplicated
sister chromatids to two daughter cells must be orchestrated
with cytokinesis. A key component coordinating this process is
the chromosome passenger complex (CPC), which consists of
the enzymatic component Aurora B and three regulatory compo-
nents: INCENP, survivin, and borealin (reviewed by Carmena
et al., 2012). The CPC is essential for proper chromosome con-
gression in early mitosis at the centromeres, while it relocates to
the spindle midzone and equatorial cortex (hereby called the cell166 Cell Reports 7, 166–179, April 10, 2014 ª2014 The Authorsequator) in latemitosis (Cooke et al., 1987; Earnshaw andCooke,
1991) to promote furrow ingression for cytokinesis.
The CPC relocation event starts at the metaphase-to-
anaphase transition, a point of no return that is tightly regulated
bymaintaining Cdk1/cyclin B1 kinase activity (reviewed byRhind
and Russell, 2012). For this transition to occur, bipolar spindle
attachment must be completed in order for the anaphase-pro-
moting complex (APC) to degrade cyclin B1 that inactivates
Cdk1. In budding yeast, Cdk1 and Cdc14p phosphatase antag-
onistically control Sli15/INCENP for Ipl1/Aurora B localization
(Mirchenko and Uhlmann, 2010; Nakajima et al., 2011; Pereira
and Schiebel, 2003). In mammalian cells, Cdk1/cyclin B1 phos-
phorylation of INCENP at the Thr-59 residue has an inhibitory
effect on CPC relocation (Goto et al., 2006; Hu¨mmer and Mayer,
2009). However, the mechanistic basis of the spatiotemporal
redistribution of the CPC upon anaphase onset remains elusive,
particularly in mammalian cells. Furthermore, despite the
requirement of MKlp2 kinesin for CPC relocation and cytokinesis
in mammalian cells (Gruneberg et al., 2004; Hill et al., 2000), the
mechanism of spatiotemporal recognition between MKlp2 and
the CPC at anaphase onset is unclear.
Here, we show a key regulatory mechanism that controls
activation of MKlp2 at the appropriate time in the cell cycle
via Cdk1/cyclin B1-mediated phosphoregulation. In brief, we
demonstrate that Cdk1/cyclin B1-mediated inhibitory phos-
phorylation of MKlp2 is essential for proper early mitotic
progression. Upon anaphase onset, however, reversing this
phosphorylation is necessary for timely activation of MKlp2
kinesin to relocate the CPC from anaphase chromosomes for
cytokinesis. Thus, Cdk1/cyclin B1-mediated phosphoregulation
ensures that activation of MKlp2 kinesin and relocation of the
CPC occur at the appropriate time and space for proper mitotic
progression.
RESULTS
Cdk1/Cyclin B1-Dependent Phosphorylation ofMKlp2 in
Early Mitosis
It is unclear how MKlp2 kinesin function is controlled during
mitotic progression. Notably, whenHeLa cells arrested inmitosis
by the microtubule depolymerizer nocodazole (Noco) were
briefly treated with the Cdk1 inhibitor purvalanol A (PurvA),
endogenous MKlp2 showed band-shifting into a form of higher
mobility in Phos-tag SDS-PAGE (Figure 1A), suggesting dephos-
phorylation. To evaluate the possibility of phosphoregulation
of MKlp2, HeLa cell lines engineered to express Flag-tagged
MKlp2 (Flag-MKlp2) at endogenous levels upon doxycycline
(Dox) treatment (Kitagawa et al., 2013) were synchronized in
prometaphase-like state by Noco treatment. After release, cells
were harvested at different time points. Phos-tag SDS-PAGE
revealed the mitotic mobility shift of the Flag-MKlp2WT band
gradually collapsing at anaphase onset (marked by a decrease
in cyclin B1 levels) (Figure 1B). Although the amount of extracted
Flag-MKlp2WT also decreased after anaphase onset (Figure 1B,
lanes 3 and 4), it was mainly due to Flag-MKlp2WT becoming less
soluble (Figures 2E, 2F, and 4C). Moreover, treating immunopuri-
fied Flag-MKlp2WT with alkaline phosphatase (ALP) also caused
band-shifting (Figure 1C, lanes 3 and 4), suggesting that MKlp2
is phosphorylated in early mitosis.
Human MKlp2 contains seven putative, evolutionarily
conserved proline-directed Cdk1 phosphorylation sites (Fig-
ure 1D; Figure S1A). Indeed, Cdk1/cyclin B1 phosphorylated
multiple proline-directed Ser/Thr residues in MKlp2 in vitro (Fig-
ure S1B). Thus, to determine whether the band-shifting of Flag-
MKlp2WT was due to phosphorylation of these residues, we
substituted all putative phosphoresidues with alanine (MKlp27A;
Figure 1D). Indeed, Flag-MKlp27A did not show a measurable
band-shifting unlike Flag-MKlp2WT (Figure 1E, lanes 2 and 4),
even after ALP treatment (Figure 1C, lanes 7 and 8), suggesting
that MKlp2 is phosphorylated on all or some proline-directed
Ser/Thr residues. Thus, we conclude that MKlp2 is phosphory-
lated in early mitosis (at least in mitotic-arrested cells with spin-
dle damages) in a Cdk1/cyclin B1-dependent manner.
Cdk1/Cyclin B1 Restrains MKlp2 in the Cytoplasm in
Early Mitosis
Next, whether Cdk1/cyclin B1-dependent phosphorylation con-
trols MKlp2 localization was tested. Notably, while endogenous
MKlp2 localized in the cytoplasm of metaphase-arrested HeLa
cells by the proteasome inhibitor MG132, a brief PurvA treatment
for 2 min caused a dramatic redistribution of MKlp2 to the
metaphase spindles, chromosomes, and the cell cortex without
apparent chromosome separation (Figure 1F). Furthermore,
in metaphase-arrested HeLa cells, Dox-induced Flag-MKlp27A,
but not Flag-MKlp2WT, constitutively localized to the metaphase
spindles, chromosomes, and the cell cortex and induced
misalignedchromosomes (Figure1G,arrows; seealsoFigure3H).
Consistent with this localization pattern of MKlp2 determined by
immunofluorescence staining, transiently expressed mCherry-
tagged MKlp27A, but not MKlp2WT, showed a similar localization
pattern inHeLacells arrestedby inhibitingcentrosomeseparation
with the Eg5 inhibitor S-trityl-L-cysteine (STLC) (Figure 1H, sub-
panels a and b; Figure 1I). Thus, we conclude that Cdk1/cyclin
B1 restrains MKlp2 in the cytoplasm in early mitosis.
Notably, alanine substitutions at the Ser-532, Thr-857,
Ser-867, and Ser-878 residues (MKlp2C-4A) in the stalk and
C-terminal tail domains were sufficient to induce MKlp2 redis-
tribution (Figure 1H, subpanel c; Figure 1I), although slightlyweaker than MKlp27A (Figures 3C, 3D, 5G, and 5H). In contrast,
alanine substitutions at the Ser-7 and Ser-21 residues in the
N-terminal tail (MKlp2N-2A) weakly caused MKlp2 redistribution
to chromosomes (Figure 1I). Alanine substitution at the Thr-198
residue did not cause measurable changes (M.K. and S.H.L.
unpublished data). Furthermore, none of phosphomimetic
mutants (generated by glutamate substitution) showed any
measurable redistribution (Figure 1I). Interestingly, phospho-
proteomic analysis (http://www.phosphosite.org) indicates
that these 4 residues in the stalk and C-terminal tail domains
are frequently phosphorylated. To determine the phosphoryla-
tion status of these residues in vivo, phosphospecific (pS-532,
pS-867, and pS-878) antibodies were generated and validated
for specificity (Figure S2). The phosphorylation status of the
Thr-857 residue was determined by antibodies against a phos-
pho-Thr-Pro motif (p-TP). Indeed, all phosphospecific anti-
bodies strongly cross-reacted with Dox-induced Flag-MKlp2WT
in Noco-arrested HeLa cells, while PurvA treatment abolished
such reactivity (Figure 1J, lanes 1 and 5). Notably, using these
phosphospecific antibodies as indicators, these phosphoresi-
dues were rapidly dephosphorylated upon anaphase onset
(marked by a decrease in cyclin B1 levels) (Figure 1J). Thus,
we conclude that Cdk1/cyclin B1 controls spatiotemporal
localization of MKlp2 during mitotic progression via promoting
phosphorylation of at least the stalk and C-terminal tail do-
mains. This phosphorylation restrains MKlp2 in the cytoplasm
in early mitosis.
Phosphoregulation of MKlp2 in Higher-Order Complex
Formation, Direct Microtubule Binding, and
Chromosome Targeting
Folding the tail and motor domains of kinesin together is a
proposed mechanism for inhibiting kinesin motor (reviewed by
Verhey and Hammond, 2009). Thus, whether C-terminal phos-
phorylation may maintain MKlp2 in a folded state was tested us-
ing recombinant MBP-tagged C-terminal tail (amino acids [aa]
710–890; MBP-MKlp2710–890 and MBP-MKlp2710–890/C-3E) and
His-tagged N-terminal domain (aa 1–510; 6xHis-MKlp21–510)
(Figure 2A). In contrast to our hypothesis, MBP-MKlp2710–890
formed a complex with 6xHis-MKlp21–510 (Figure 2B, lanes
1–7) with patterns of sequential interaction (Figure 2C; KD =
5.1 mM and KD = 15.6 mM), while the phosphomimetic mutant
MBP-MKlp2710-890/C-3E failed to do so in MBP-pull-down (Fig-
ure 2B, lanes 8–14) and isothermal titration calorimetry (ITC)
assays (M.K. and S.H.L., unpublished data). Thus, Cdk1/cyclin
B1-dependent phosphorylation may prevent the C-terminal tail
from interacting with the motor domain.
Moreover, determined by sucrose density gradient centrifuga-
tion of cell lysates expressing mCherry-MKlp2, the majority of
MKlp2WT or the phosphoresistant MKlp2C-4A was found in the
bottom fractions (Figure 2D). In contrast, the phosphomimetic
MKlp2C-4E migrated much slower (Figure 2D), indicating that
Cdk1/cyclin B1-dependent phosphorylation may inhibit higher-
order complex formation (oligomerization/clustering or binding
to large cellular components) of MKlp2. Previously characterized
biochemical properties of the kinesin-6 family member MKlp1
becoming less soluble in low-ionic-strength solutions as well
as during cytokinesis explains its tendency to assemble intoCell Reports 7, 166–179, April 10, 2014 ª2014 The Authors 167
Figure 1. Cdk1/Cyclin B1-Dependent Phosphorylation Restrains MKlp2 in the Cytoplasm in Early Mitosis
(A–C and E) Phos-tag SDS-PAGE analysis of immunoprecipitated endogenous MKlp2 (A) or Flag-MKlp2 (B, C, and E). Noco-arrested HeLa cells were treated
with PurvA (A) or synchronously released from Noco-block (B). Immunopurified Dox-induced Flag-MKlp2 was treated with ALP for 1 hr (C). Arrows indicate the
slow-migrating hyperphosphorylated MKlp2, while arrowheads indicate the fast-migrating hypophosphorylated forms.
(D) Structural motifs ofMKlp2 and putative proline-directed Ser (Sp)/Thr (Tp) phosphosites are shown (top). The list of phosphoresistantmutants used in this study
is shown (bottom).
(F) HeLa cells were treated with MG132 (10 mM) for 1 hr and then with DMSO (subpanel a) or PurvA (subpanel b) before fixing in ice-cold methanol.
(G) Images of Dox-induced Flag-MKlp2 at metaphase. Dox-inducible HeLa cells were treated with Dox for 24 hr and MG132 for 1.5 hr before fixing in ice-cold
methanol. Arrows indicate misaligned chromosomes (subpanel b).
(H and I) HeLa cells stably expressing GFP-a-tubulin were transfected with expression vectors encoding the indicated siRNA-resistant mCherry-MKlp2 together
withMKlp2 siRNA for 6 hr. The cells were subsequently treatedwith STLC for 16 hr before fixing in ice-coldmethanol. (I) The percentages of cells with an indicated
pattern of mCherry-MKlp2 localization are shown (n > 100 cells per condition).
(J) Noco-arrested HeLa cells with Dox-induced Flag-MKlp2WT were harvested at indicated times after synchronously released (lanes 1–4). Total cell lysates
were subjected to immunoprecipitation using a-Flag antibodies followed by immunoblot analysis including indicated phosphospecific antibodies. For lane 5,
Noco-arrested cells were treated with PurvA before harvesting.
White bars in (F)–(H) represent 5 mm.
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motile clusters and stable accumulation at the spindle midzone
(Hutterer et al., 2009; Mishima et al., 2002). Notably, when
Noco-arrested HeLa cells were synchronously released, Flag-
MKlp2WT also became gradually less soluble as the levels of
cyclin B1 declined (Figure 2E), indicating Cdk1/cyclin B1 phos-
phorylation may control solubility of MKlp2. Indeed, using
pS-532 antibodies, only the dephosphorylated pool of MKlp2
preferentially became insoluble (Figure 2E). Furthermore, PurvA
treatment to Noco-arrested HeLa cells induced Flag-MKlp2WT,
but not Flag-MKlp2C-4E, insolubility (Figure 2F). Thus, we
conclude that Cdk1/cyclin B1-dependent phosphorylation in-
hibits higher-order complex formation and promotes solubility
of MKlp2 (possibly inhibiting oligomerization/clustering or inter-
action with large cellular components [e.g., microtubules, actin
filaments, or chromosomes]).
Because the phosphoresistant mutant of MKlp2 prematurely
localized to microtubules (Figures 1G–1I), instead of a folded-
state model, we tested whether the C-terminal tail possesses a
cryptic microtubule binding site. This idea was conceivable as
an evolutionarily conserved stretch of basic residues (arrows)
surrounds the phosphoresidues (asterisks) in this tail (Figure 2G).
Indeed, in vitro microtubule cosedimentation analysis showed
that MBP-MKlp2710–890 directly bound microtubules, while the
phosphomimetic MBP-MKlp2710–890/C-3E did so less efficiently
(Figure 2H). This microtubule binding is charge dependent
because increasing the salt concentration (potassium chloride
[KCl]) decreased the microtubule binding of MBP-MKlp2710–890
(Figure 2H, top panel), while a lower salt concentration abol-
ished the microtubule binding of MBP-MKlp2710-890/C-3E
(bottom panel). Thus, the Arg/Lys/His-rich basic clusters in
the C-terminal tail directly mediate microtubule binding in a
charge-dependent manner, whereas Cdk1/cyclin B1-dependent
phosphorylation may inhibit this interaction.
To validate MKlp2’s microtubule binding via the C-terminal
tail in vivo, motorless phosphoresistant mutants (mCherry-
MKlp2510–890/C-4A and mCherry-MKlp2710–890/C-3A) were tran-
siently expressed in STLC-arrested HeLa cells. These phosphor-
esistant mutants sufficiently localized to monopolar spindles
(Figure 2I, subpanels c and d). In contrast, mCherry-MKlp2WT
was largely restrained in the cytoplasm (subpanel a), and
mCherry-MKlp2510–890 was localized in the cytoplasm as well
as weakly to chromosomes (subpanel b). Thus, the C-terminal
tail of MKlp2 also mediates microtubule binding in vivo, while
Cdk1/cyclin B1-dependent phosphorylation inhibits this
activity. Notably, the stalk domain was required for chromo-
some targeting, because mCherry-MKlp2510–890/C-4A, but not
MKlp2710–890/C-3A, also localized to chromosomes (Figure 2I,
subpanels c and d). This was evident when microtubules were
depolymerized by Noco treatment (Figure 2J). Taken together,
we conclude that the stalk and C-terminal tail domains represent
the crypticmicrotubule binding, higher-order complex formation,
and chromosome targeting sites in MKlp2, whereas Cdk1/cyclin
B1 phosphorylation may inhibit these abilities of MKlp2.
Cdk1/Cyclin B1-Dependent Phosphorylation Inhibits
MKlp2 for Proper Early Mitotic Progression
Next, we determined the effects of premature microtubule
binding ofMKlp2 on spindle dynamics using fluorescence recov-ery after photobleaching (FRAP) analysis. For this purpose,
mCherry-MKlp2 was transiently expressed in STLC-arrested
HeLa cells stably expressing GFP-a-tubulin. Notably, the dy-
namic exchange rate of the phosphoresistant MKlp2 mutants
(MKlp27A and MKlp2C-4A) between the monopolar spindles and
cytoplasm was slower than MKlp2WT (Figures 3A–3C), indicating
a stable binding to spindles. Moreover, these mutants markedly
decreased the turnover rate of monopolar spindles (Figures 3A,
3B, and 3D). Thus, these mutants alter spindle dynamics,
possibly by enhancing microtubule stability.
Proper spindle dynamics are essential for bipolar spindle
formation and chromosome congression (reviewed by Meunier
and Vernos, 2012). When HeLa cells stably expressing
GFP-histone H2B (chromosome marker) were released from
STLC-induced mitotic arrest, transiently expressed mCherry-
MKlp2WT was largely present in the cytoplasm until the
completion of chromosome congression, while it localized to
chromosomes and subsequently to the midzone in anaphase
(Figure 3E; Movie S1). In contrast, mCherry-MKlp2C-4A strongly
bound to microtubules and disrupted chromosome congres-
sion (Figures 3F and 3G; Movies S2 and S3 including MKlp27A),
while the phosphomimetic mutant MKlp2C-4E did not (Movie
S4). Moreover, Dox-induced phosphoresistant mutants of
Flag-MKlp2 also markedly increased the number of cells with
misaligned chromosomes (Figure 3H; see also Figure 1G,
subpanel b). Of note, given the essential role of the CPC in
chromosome congression, it is possible that MKlp2C-4A may
also perturb the CPC in regulating chromosome congression.
Nonetheless, these results suggest that Cdk1/cyclin B1-
dependent phosphorylation inhibits MKlp2 for proper early
mitotic progression.
Cdk1/Cyclin B1 Inhibits MKlp2’s Oligomerization/
Clustering and Microtubule Bundling In Vitro
To directly investigate whether MKlp2 induces oligomerization/
clustering and microtubule bundling in a Cdk1/cyclin B1-depen-
dent manner in vitro, recombinant full-length MKlp2WT and
nonphosphorylatable mutant MKlp27A were purified to near
homogeneity using a baculovirus expression system (Figure 4A).
Inclusion of purified Cdk1/cyclin B1 efficiently phosphorylated
MKlp2WT, but not MKlp27A, as determined using phosphospe-
cific antibodies (Figure 4B, lanes 5–8). Notably, MKlp2WT and
MKlp27A became equally insoluble only in low-ionic-strength
solutions (Figure 4C, top panels, lane 2), suggesting that this
insolubility was charge dependent. Importantly, Cdk1/cyclin B1
phosphorylation significantly increased solubility of MKlp2WT,
but not MKlp27A (Figure 4C, bottom panels, lane 2), suggesting
that Cdk1/cyclin B1 phosphorylation controls solubility of
MKlp2. Moreover, as determined by sucrose density gradient
centrifugation, MKlp2WT andMKlp27A in low-ionic-strength solu-
tions were found in the fractions 5–7 (Figure 4D, middle panels),
while both proteins migrated much slower in high-ionic-strength
solutions (top panels), indicating oligomerization/clustering of
MKlp2 in a charge-dependent manner. Notably, Cdk1/cyclin B1
phosphorylation also significantly slowed migration of MKlp2WT,
but not MKlp27A, in low-ionic-strength solutions (Figure 4D, bot-
tom panels). Of note, sucrosemight be inhibitory for oligomeriza-
tion/clustering of MKlp2 as increasing sucrose concentrationCell Reports 7, 166–179, April 10, 2014 ª2014 The Authors 169
(legend on next page)
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promoted solubility of MKlp2WT (Figure S3), indicating that the
sedimentation coefficient of MKlp2 (Figure 4D) is likely underrep-
resented. Nonetheless, these results suggest that Cdk1/cyclin
B1 phosphorylation inhibits MKlp2’s oligomerization/clustering.
Moreover, Cdk1/cyclin B1 phosphorylation also suppressed
the in vitro microtubule bundling activity of MKlp2WT, but not
MKlp27A (Figures 4E and 4F). Together with time-lapse live-cell
analysis (Figure 3), these results suggest that Cdk1/cyclin B1-
mediated phosphorylation may prevent MKlp2 from perturbing
spindle dynamics for proper early mitotic progression.
Cdk1/Cyclin B1-Dependent Phosphorylation Controls
Timely Recruitment of MKlp2 to Chromosomes
Although small interfering RNA (siRNA)-mediated knockdown of
MKlp2 blocks CPC relocation from anaphase chromosomes
(Gruneberg et al., 2004), how the spatial recognition between
MKlp2 and the CPC occurs is unknown. Notably, although
endogenous MKlp2 localized in the cytoplasm and weakly to
chromosomes in Noco-arrested HeLa cells, PurvA treatment
markedly recruited MKlp2 to chromosomes, whereas pretreat-
ing with calyculin A (CalA) to inhibit the major Ser/Thr phospha-
tases PP1/PP2A was able to exclude MKlp2 from chromosomes
even after PurvA treatment (Figures 5A and 5B). Thus, Cdk1/
cyclin B1 and PP1/PP2A regulate MKlp2’s chromosome target-
ing. Similarly, mCherry-MKlp2C-4A constitutively localized to
chromosomes (and also to the cell cortex) in Noco-arrested
HeLa cells, while mCherry-MKlp2C-4E was excluded from chro-
mosomes (Figure 5C). Moreover, live-cell time-lapsemicroscopy
analysis revealed that mCherry-MKlp2WT targeted to chromo-
somes immediately after PurvA treatment, whereas neither
mCherry-MKlp2C-4A nor mCherry-MKlp2C-4E was sensitive
to PurvA treatment (Figure 5D; Movie S5). Consistently, FRAP
analysis revealed that the dynamic exchange rate of the
phosphoresistant mutants between chromosomes and the cyto-
plasm in Noco-arrested HeLa cells was slower than wild-type
(Figure 5E–5H). Of note, this chromosome targeting may be via
the core histones, because affinity purification using the minimal
chromosome binding motif of MKlp2 (Figure 6I) showed that
nearly stoichiometric amounts of histone polypeptides wereFigure 2. Phosphoregulation of MKlp2’s Higher-Order Complex Forma
(A) Coomassie blue staining of purified recombinant proteins from E. coli.
(B) Silver staining of 6xHis-MKlp2 motor domain precipitates with the indicated M
(C) Isothermal titration calorimetry (ITC) assay. The record of heat exchange (top)
are shown.
(D) Lysates of asynchronously growing HeLa cells expressing the indicated mCh
removed from the top (lane 1), separated by SDS-PAGE, and immunoblotted with
in each fraction are plotted (bottom graph).
(E and F) Noco-arrested HeLa cells with Dox-induced Flag-MKlp2 were harveste
Flag-MKlp2 in supernatant (S) and pellet (P) fractions was analyzed by immunoblo
a-Flag antibodies (E).
(G) Sequence alignment (Clustal Omega) of the C-terminal tail of MKlp2 with hom
with amino acid numbers. Arrows indicate conserved basic Arg/Lys/His residues
(H) Purified recombinant MBP-MKlp2 tail domains in increasing concentration
ultracentrifuged. The equal percentages of resulting supernatant (S) and pellet (P
ratios (S/P) between the supernatant and pellet fractions are indicated (E), (H).
(I and J) HeLa cells stably expressing GFP-a-tubulin were transfected with ex
were subsequently treated with STLC (I) or Noco (J) for 16 hr. The percentages
chromosomes (J) are indicated (n > 100 cells per condition).
White bars in (I) and (J) represent 5 mm.detected in mass spectrometry analysis after SDS-PAGE
and silver staining (M.K. and S.H.L., unpublished data).
Thus, we conclude that Cdk1/cyclin B1-dependent phosphory-
lation controls timely recruitment of MKlp2 to chromosomes
where the spatial recognition between MKlp2 and the CPC
may occur.
Reversing Cdk1/Cyclin B1-Dependent Phosphorylation
of MKlp2 Is Necessary for Relocating the CPC from
Anaphase Chromosomes to the Cell Equator for
Cytokinesis
Our findings revealed that Cdk1/cyclin B1-dependent inhibitory
phosphorylation of MKlp2 is essential for proper early mitotic
progression. Next, we tested whether reversing this inhibitory
phosphorylation is required for MKlp2’s function in relocating
the CPC during anaphase progression. As expected, the knock-
down of endogenous MKlp2 completely blocked Aurora B
relocation from anaphase chromosomes, while Dox-induced
siRNA-resistant Flag-MKlp2WT efficiently rescued it (Figure 6A,
subpanels a and b; Figure 6B). In contrast, Dox-induced
phosphomimetic mutant Flag-MKlp2C-4E localized to neither
anaphase chromosomes nor the cell equator, and it failed
to relocate Aurora B from anaphase chromosomes in MKlp2-
depleted cells (Figure 6A, subpanels c and d; Figure 6B), leading
to the increased number of binucleated cells from failed cytoki-
nesis (Figure 6C). Notably, this defect was not due to a failure
in reversing inhibitory phosphorylation of INCENP at the Thr-59
residue in anaphase (Figure S5A). Moreover, a directed two-
hybrid assay revealed that MKlp2WT and MKlp2C-4A efficiently
interacted with INCENP, while the phosphomimetic MKlp2C-4E
failed to do so (Figure 6D, top panel), despite comparable
expression of MKlp2C-4E to MKlp2WT in cell lysates from yeast
(bottom panel). Similarly, as determined by immunoprecipitation
analysis using Noco-arrested HeLa cells, Dox-induced Flag-
MKlp2WT efficiently bound to INCENP and Aurora B upon
inactivation of Cdk1 (Figure 6E, lanes 5 and 6), whereas Flag-
MKlp2C-4E did not (lanes 7 and 8). Notably, a directed two-hybrid
assay revealed that the N-terminal domain of INCENP encom-
passing aa 1–58 (INCENP1-58) was responsible for bindingtion, Direct Microtubule Binding, and Chromosome Targeting
BP-MKlp2 tail domains.
and the fitted binding isotherm assuming a sequential binding model (bottom)
erry-MKlp2 were subjected to sucrose gradient sedimentation. Fractions were
a-mCherry antibodies (top panels). The quantification results of band intensities
d at indicated times after synchronously released (E) or treated with PurvA (F).
t. For a-pS532, total cell lysates were subjected to immunoprecipitation using
ologs from different species. Asterisks indicate Cdk1/cyclin B1 phosphosites
.
s of KCl were incubated with or without taxol-stabilized microtubules and
) fractions (10% of total) were analyzed by silver staining. The band intensity
pression vectors encoding the indicated mCherry-MKlp2 for 6 hr. The cells
of cells with mCherry-MKlp2 strongly localized to monopolar spindles (I) or
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Figure 3. Cdk1/Cyclin B1-Dependent Phosphorylation Inhibits MKlp2’s Microtubule Binding for Proper Spindle Dynamics and Chromosome
Congression
(A–D) FRAP analysis. HeLa cells stably expressing GFP-a-tubulin were transfected with expression vectors encoding the indicated siRNA-resistant mCherry-
MKlp2 together with MKlp2 siRNA for 6 hr and subsequently treated with STLC for 16 hr. A selected area of the cell (yellow circle) was photobleached with the l =
543 and l = 488 laser lines (A and B), and FRAP was measured as the increase of mCherry-MKlp2 and GFP-a-tubulin fluorescence after photobleaching in the
selected area. (C and D) The average percentages of fluorescence recovery (n = 5 cells per condition, ±SD) are shown.
(E–G) Time-lapse live-cell images. HeLa cells stably expressing GFP-histone H2B were transfected as described above (A–D). The cells were subsequently
treated with STLC for 16 hr and released.
(H) Dox-inducible HeLa cells treated with Dox during the thymidine block were released from the G1/S boundary and subsequently arrested using STLC
treatment. Then, the cells were released in fresh medium containing MG132 for 1.5 hr to induce chromosome congression and fixed for immunofluorescence
analysis. The average percentages based on three independent experiments of cells expressing Flag-MKlp2 with misaligned chromosomes (n > 100 per con-
dition, ±SD) are shown.MKlp2WT, while it failed to bind MKlp2C-4E (Figure 6F). Further-
more, recombinant glutathione S-transferase (GST)-tagged
INCENP1–58 purified from E. coli (Figure 6G, lane 2) was able to
bind recombinant MKlp2WT and MKlp27A (lanes 3 and 4), while
Cdk1/cyclin B1 phosphorylation of MKlp2WT, but not MKlp27A,
inhibited this interaction in vitro (lanes 7 and 8). Of note, both
INCENPWT and INCENPT59E comparably interacted with
MKlp2WT in a directed two-hybrid, quantitative b-galactosidase
and GST pull-down assay, while MKlp2C-4E failed to bind
INCENPWT and INCENPT59E in immunoprecipitation assay (Fig-
ures S5B–S5D). Thus, these results indicate that reversing
Cdk1/cyclin B1-dependent phosphorylation of MKlp2 may172 Cell Reports 7, 166–179, April 10, 2014 ª2014 The Authorspromote the formation of a CPC:MKlp2 complex (possibly via
INCENP) to mediate CPC relocation for cytokinesis.
To further test the importance of reversing the phosphoinhibi-
tion of MKlp2 in CPC relocation, hemagglutinin (HA)-tagged
phosphoresistant INCENP (HA-INCENPT59A) was transiently ex-
pressed in Dox-induced HeLa cells expressing Flag-MKlp2.
Although Dox-induced Flag-MKlp2WT efficiently relocated to
the cell equator together with HA-INCENPT59A, Flag-MKlp2C-4E
was unable to remove HA-INCENPT59A from anaphase chromo-
somes (Figure 6A, subpanels e and f), indicating that reversing
the inhibitory phosphorylation of MKlp2 is required for relocating
INCENP independent of dephosphorylation at the Thr-59
Figure 4. Cdk1/Cyclin B1 Inhibits MKlp2’s Oligomerization/Clustering and Microtubule Bundling In Vitro
(A) Coomassie blue staining of purified recombinant full-length MKlp2WT and MKlp27A from Sf9 cells.
(B) PurifiedMKlp2 proteins (0.25 mg) were subjected to in vitro kinase assay with or without active Cdk1/cyclin B1 (0.1 mg). Phosphorylated MKlp2 was evaluated
by Coomassie blue staining (lanes 1–4) and immunoblot analysis (lanes 5–8) using indicated phosphospecific antibodies.
(C) Solubility of phosphorylated or nonphosphorylatedMKlp2was assayed after dilution into buffers with increasing concentrations of NaCl and analyzed by silver
staining. T, total; S, supernatant.
(D) Sucrose gradient sedimentation of phosphorylated or nonphosphorylatedMKlp2. Fractions were removed from the top (lane 1) and analyzed with immunoblot
using a-MKlp2 antibodies. The sedimentation of the size standards malate (M; 4.3 S), catalase (C; 11.3 S), and thyroglobulin (T; 19.3 S) is indicated (bottom).
(E) Microtubule bundling assay. The panels show the distribution of microtubules. White bars represent 5 mm.
(F) The extent of microtubule bundling was quantified from ten random fields of samples (E) and the number of microtubules bundled per field were counted. The
average numbers of microtubules bundled per conditions (±SD) are shown.
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Figure 5. Cdk1/Cyclin B1 Inhibits MKlp2 Targeting to Chromosomes
(A) Noco-arrested HeLa cells were treatedwithMG132 for 1 hr (a–c) and thenwith DMSO (subpanel a) or PurvA (subpanel b) before fixing in ice-coldmethanol. For
subpanel c, the cells were treated with CalA before the addition of PurvA.
(B) Quantification of the chromosome localization of endogenous MKlp2. The ratio (n = 10 per condition, ±SD) of the chromosome fluorescence to non-
chromosome fluorescence was calculated as described in the y axis legend. The inset showsMKlp2 concentrates on chromosomes in Noco-arrested HeLa cells
after PurvA treatment. Circles indicate regions used for the quantification of the extent of chromosome localization (yellow) and total localization (red).
(C and D) HeLa cells were transfected with expression vectors encoding the indicated mCherry-MKlp2 for 6 hr and subsequently treated with Noco for 16 hr. (C)
The cells were fixed in ice-cold methanol. (D) The cells were treated with MG132 for 1 hr. Upon DMSO (subpanel a) or PurvA (subpanel b) treatment, the
accumulation of mCherry-MKlp2 on chromosomes was monitored with time-lapse live-cell microscopy analysis (top) and quantified (bottom, n = 10 cells
per condition, ±SD).
(E–H) FRAP analysis. HeLa cells stably expressing GFP-histone H2B were transfected with expression vectors encoding the indicated siRNA-resistant mCherry-
MKlp2 together with MKlp2 siRNA for 6 hr. The cells were subsequently treated with Noco for 16 hr. A selected area of the cell (yellow circle) was photobleached
with the l = 543 and l = 488 laser lines (E and F), and FRAP was measured as the increase of mCherry-MKlp2 and GFP-histone H2B fluorescence after
photobleaching in the selected area. (G and H) The average percentages of fluorescence recovery (n = 5 cells per condition, ±SD) are shown.residue. Furthermore, when these cells were subsequently
arrested in the monopolar state by STLC and briefly treated
with PurvA (Canman et al., 2003), Flag-MKlp2WT relocated
together with HA-INCENPT59A to the monopolar spindles (Fig-
ure 6H, subpanel b). In contrast, CalA treatment prevented
Flag-MKlp2WT from relocating HA-INCENPT59A from chromo-
somes (Figure 6H, subpanel c). Under this condition, Flag-
MKlp2WT was restrained in the cytoplasm (Figure 6H, subpanel
c), similar to Flag-MKlp2C-4E in anaphase (Figure 6A, subpanels
d and f). Together, these results suggest that reversing Cdk1/
cyclin B1-dependent phosphorylation allows MKlp2 to relocate
the CPC.174 Cell Reports 7, 166–179, April 10, 2014 ª2014 The AuthorsFinally, to test whether MKlp2’s chromosome targeting indeed
contributes to CPC relocation from anaphase chromosomes, we
identified that amino acid residues encompassing 510–840
(MKlp2510–840) were sufficient for MKlp2’s chromosome target-
ing, but not microtubule binding (Figure 6I; Figure S4). Notably,
using HeLa cells stably expressing mCherry-tagged Aurora B,
transiently targeting GFP-MKlp2510–840 to chromosomes mark-
edly suppressed mCherry-Aurora B relocation from anaphase
chromosomes, while GFP-histone H2B (as chromosome target-
ing control) did not (Figure 6J). This indicates that MKlp2510–840
may outcompete endogenous MKlp2 for recognition of the
CPC at anaphase chromosomes. Taken together, we conclude
that reversing Cdk1/cyclin B1-mediated inhibitory phosphoryla-
tion contributes to timely activation of MKlp2 and relocation of
the CPC (possibly via INCENP) from anaphase chromosomes.
Furthermore, this event promotes MKlp2’s abilities for microtu-
bule binding and bundling as well as oligomerization/clustering,
which may contribute to central spindle assembly/stabilization
and clustering/activation of the CPC at the cell equator for robust
furrow ingression (Figure 7). Thus, this key phosphoregulatory
step connects early and late mitotic events for proper mitotic
progression.
DISCUSSION
Here, we show that several aspects ofMKlp2 kinesin function are
negatively regulated by Cdk1/cyclin B1-dependent phosphory-
lation. Notably, the C-terminal basic stretches of MKlp2 directly
interact with tubulin (possibly via C-terminal ‘‘E-hook’’ acidic
tail), while Cdk1/cyclin B1 phosphosites embedded in these
basic stretches would inhibit MKlp2’s microtubule binding
during early mitosis, similar to MKlp1/ZEN-4 (Mishima et al.,
2004). Likewise, the N-terminal unstructured basic tail of
Ndc80, the microtubule binding element of kinetochore, medi-
ates high-affinity microtubule binding (Ciferri et al., 2008; DeLuca
et al., 2006; Guimaraes et al., 2008; Miller et al., 2008; Wei et al.,
2007), which is inhibited by Aurora B phosphorylation (Alushin
et al., 2012). Similarly, the C-terminal Lys/Arg-rich domain of
PRC1 enhances microtubule binding and crosslinking antipar-
allel microtubules for central spindle formation (Subramanian
et al., 2010), while this unstructured domain is subjected to
Cdk1/cyclin B1 phosphoregulation (Zhu et al., 2006). Based on
protein secondary structure prediction, the C-terminal tail of
MKlp2 is unstructured. Thus, it is conceivable that this unstruc-
tured tail could provide a wide range of orientations and func-
tions. Indeed, we show that this C-terminal tail also forms a
complex with its motor domain in patterns of sequential inter-
action. Thus, upon initial contact with the motor domain, the
unstructured C-terminal tail of MKlp2 may induce conformation
adaptation to promote intimate complex formation in a head-
to-tail geometry, thus clustering. Similarly, the disordered N-ter-
minal tail of Ndc80 interacts with the E-hook of tubulin and
induces Ndc80 clustering (Alushin et al., 2010, 2012), suggesting
that microtubule binding and cluster formation are intimately
connected.
We also show that Cdk1/cyclin B1 phosphorylation inhibits
oligomerization/clustering and microtubule bundling of MKlp2
in order to avoid premature stabilization and bundling of micro-
tubules that causes defects in chromosome congression in
early mitosis. In anaphase, however, Cdk1/cyclin B1-dependent
inhibitory phosphorylation must be reversed by PP1/PP2A for
timely activation of MKlp2. This mechanism may be a way for
clustered MKlp2 at microtubule plus ends to capture and bundle
antiparallel microtubules near the cortical equator. Furthermore,
multimerized MKlp2 may also stably cluster and activate the
CPC at the cell cortex and subsequently at the actomyosin
filaments for robust furrow ingression (Kitagawa et al., 2013).
Evidently, the mechanism by which the CPC and clustered
MKlp2 complex engage microtubule plus ends and ingressing
furrow is an important area for future research.Our findings also suggest that the spatiotemporal recognition
between MKlp2 and the CPC may occur at anaphase chromo-
somes. Notably, we show that MKlp2 dynamically localizes to
chromosomes. This event is also inhibited by Cdk1/cyclin B1
that is opposed by PP1/PP2A. Moreover, when the motif
responsible for MKlp2’s chromosome targeting is ectopically ex-
pressed, it blocks Aurora B relocation from anaphase chromo-
somes, suggesting that MKlp2 may remove the CPC from
anaphase chromosomes. However, this preferential chromo-
some targeting of MKlp2 upon inhibition of Cdk1 is unexpected,
because the phosphoresistant mutant binds microtubules much
stronger than chromosomes based on our FRAP analysis. This
difference may be explainable if the phosphatase activity rele-
vant to MKlp2 is highly present at chromosomes. Alternatively,
the phosphoresidues in the stalk and C-terminal tail domains
may be dephosphorylated sequentially so that chromosome
targeting would occur prior to microtubule binding. It is also
possible that Plk1 phosphorylation (Neef et al., 2003) may also
affect MKlp2 localization in mitotic progression. Nonetheless,
the preferential recruitment ofMKlp2 to anaphase chromosomes
may be a regulatory means to achieve a spatial recognition
between MKlp2 and the CPC without perturbing microtubule
dynamics (or bundling mitotic spindles and/or kinetochore fibers
to metaphase spindles). Subsequently, this spatial regulatory
event may assist MKlp2 to transport the CPC from anaphase
chromosomes to microtubules in a temporal manner. This idea
is consistent with a notion that a subpopulation of stable micro-
tubules extends past chromosomes, which may supply microtu-
bule stability and furrowing factors from chromosomes to the
cortex (Canman et al., 2003).
We also propose that reversing Cdk1/cyclin B1-mediated
phosphorylation of MKlp2 is an essential regulatory step to
recognize the CPC possibly via INCENP. This conclusion is sup-
ported by the following results: (1) the inhibitory phosphorylation
of MKlp2 is rapidly reversed upon anaphase onset, (2) the phos-
phomimetic mutant neither binds INCENP nor relocates the CPC
regardless INCENP phosphorylation at the Thr-59 residue, and
(3) blocking MKlp2 dephosphorylation by inhibiting PP1/PP2A
also inhibits relocating INCENPT59A from chromosomes.
Although the reason why Cdk1/cyclin B1 phosphoregulates
both MKlp2 (in this study) and INCENP (Goto et al., 2006; Hu¨m-
mer and Mayer, 2009) is unclear, our results suggest that
reversing the inhibitory phosphorylation of MKlp2 may
be required for the interaction between MKlp2 and the CPC
(possibly via INCENP). Alternatively, INCENP dephosphorylation
at the Thr-59may be required for MKlp2 to recognize the CPC as
a complex or for the relocation step from anaphase chromo-
somes independent of forming the CPC:MKlp2 complex.
In summary, timely activation of MKlp2 by Cdk1/cyclin
B1-mediated phosphoregulation is an essential mechanism to
coordinate the events required for proper mitotic progression
and relocating the CPC for cytokinesis. Furthermore, our find-
ings suggest that Cdk1/cyclin B1 regulates functions of MKlp2
for proper mitotic progression, raising a possibility that misregu-
lated or overexpressed MKlp2 in many human cancers may
contribute to chromosome instability and tumorigenesis. Future
research efforts will be required for amore detailed elucidation of
the exact underlying mechanisms.Cell Reports 7, 166–179, April 10, 2014 ª2014 The Authors 175
Figure 6. Reversing Cdk1/Cyclin B1-Dependent Phosphorylation of MKlp2 Is Necessary for Relocating the CPC from Anaphase Chromo-
somes to the Cell Equator for Cytokinesis
(A and H) Immunofluorescence analysis. Dox-inducible HeLa cells were transfected for 4 hr with siRNA against MKlp2. Subsequently, the cells were treated with
Dox for 26 hr before fixing in ice-cold methanol. For (A) (subpanels e and f) and (E), expression vectors encoding HA-INCENPT59A were transfected together with
siRNA against MKlp2.
(B and C) Quantification of the average percentages of cells with Aurora B that failed to relocate to the cell equator (B) and became multinucleated due to
cytokinesis failure (C) (n > 100 cells per condition, ±SD).
(D and F) Yeast two-hybrid assay. The interaction between MKlp2 and INCENP was evaluated by colony growth as well as b-galactosidase staining assay.
(D, bottom panels) The expression levels of MKlp2 were determined by immunoblot analysis using a-MKlp2 antibodies and Coomassie blue staining (loading
control).
(legend continued on next page)
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Figure 7. Proposed Model
Cdk1/cyclin B phosphorylates multiple sites in the stalk and C-terminal tail domains of MKlp2 in early mitosis. This phosphorylation inhibits MKlp2’s microtubule
binding, oligomerization/clustering, and recruitment to chromosomes. Upon anaphase onset, however, reversing Cdk1/cyclin B1-mediated inhibitory phos-
phorylation is necessary for the timely promotion of MKlp2’s kinesin function and relocation of the CPC from anaphase chromosomes to the cell equator, possibly
via INCENPbinding. Subsequently, it promotesMKlp2’s abilities for microtubule binding and bundling as well as oligomerization/clustering thatmay contribute to
central spindle assembly/stabilization and clustering/activation of the CPC at the cell equator. This clustering event may also stably deliver the CPC near to the
cell cortex for robust furrow ingression.EXPERIMENTAL PROCEDURES
Cell Lines, Culture, and Reagents
HeLa cells including stably expressing GFP-a-tubulin, GFP-histone H2B, or
mCherry-Aurora B were maintained in Dulbecco’s modified Eagle’s medium
with 10% fetal bovine serum (Invitrogen). Vectors encoding HA-, Flag-, and
mCherry-tagged MKlp2 were previously described (Lee et al., 2010; Kitagawa
et al., 2013). For Figure 6I, indicated MKlp2 cDNAs were amplified and cloned
into the pEGFP-C1 vector. Site-directed mutagenesis was performed with
the use of a site-directed mutagenesis system (Gene Tailor; Invitrogen) and
verified by sequencing. The Dox-inducible system and siRNAswere previously
described (Kitagawa et al., 2013). Antibodies used for immunoblot and
immunofluorescence analysis are described in Supplemental Experimental
Procedures.(E) Noco-arrested HeLa cells with indicated Dox-induced Flag-MKlp2 were harve
immunoprecipitation using a-Flag antibodies followed by immunoblot analysis.
(G) Coomassie blue staining of purified recombinant proteins from E. coli (lanes 1
with or without active Cdk1/cyclin B1 (0.05 mg) and used for GST pull-down analy
analyzed by immunoblot assay.
(H) After transfection and Dox treatment for 26 hr, the cells were treated with STL
treated with CalA, PurvA, or DMSO before fixation and then subjected to immuno
area where HA-INCENPT59A relocated together with Flag-MKlp2WT to the tips of
(I) Summary of the minimal motif of MKlp2 for chromosome targeting independent
expression vectors encoding the indicated mCherry-MKlp2 for 6 hr. The cells
monopolar spindles or depolymerized microtubules, respectively, before they w
(J) Time-lapse live-cell images. HeLa cells stably expressing mCherry-Aurora B we
and subjected to time-lapse live-cell analysis. The images at 0:00 (min:s) were
captured every 5 min as the cells progressed to anaphase.Cell Synchronization, Immunoprecipitation, and Immunoblot
Analysis
For Figures 1A—1C, 1E, and 1J, HeLa cells were synchronized at the G1/S
boundary by exposure to 2 mM thymidine for 16 hr and incubated in fresh me-
dium for 10 hr. After the second thymidine block for 14 hr, cells were released
in fresh medium containing Noco (200 ng/ml) for 12 hr. From the second thymi-
dine block, Dox (5 mg/ml) was added. For Figures 1B and 1J, the cells were
collected by mitotic shake-off, washed in PBS, released in fresh medium,
and collected at the indicated time points. For Figures 1A, 1J, 2F, and 6E,
Noco-arrested cells were briefly treated with either DMSO or PurvA (30 mM;
Sigma) for 5 min before harvesting. Proteins were isolated with 1%NP-40 lysis
buffer (50 mM Tris HCl [pH 8.0], 150 mM NaCl, and 1% NP-40) containing
1 mM dithiothreitol (DTT), protease inhibitor mix (Complete Mini, Roche),
and PhosphoStop (Roche) and immunoprecipitated with 1 mg of antibodiessted after treatment with DMSO or PurvA. Total cell lysates were subjected to
and 2). Purified MKlp2 proteins (0.1 mg) were subjected to in vitro kinase assay
sis with the indicated GST-tagged proteins (0.5 mg). The bound proteins were
C, MG132, and paclitaxel to form monoasters. Where indicated, the cells were
fluorescence analysis with the indicated antibodies. Inset represents the boxed
monopolar spindles.
of microtubule binding identified in this study. HeLa cells were transfected with
were subsequently treated with STLC or Noco for 16 hr to arrest cells with
ere fixed with ice-cold methanol.
re transiently transfected with GFP-histone H2B or GFP-MKlp2510–840 for 24 hr
the cells at metaphase. The images from the same cells were continuously
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against MKlp2 (A300-879A, Bethyl) or Flag (Wako) with Protein A/G-agarose
beads (Santa Cruz) for 3 hr at 4C. The beads were washed with 1% NP-40
lysis buffer and subjected to immunoblot analysis. For Figure 1C, Flag-
MKlp2 proteins were immunopurified using FLAG M purification kit (Sigma)
and treated with ALP (FastAP, Thermo Scientific) for 1 hr at 37C. For Figures
1A–1C and 1E, Phos-tag SDS-PAGE analysis (AAL-107, Wako) was performed
according to the manufacturer’s instructions.
Immunofluorescence, FRAP, and Time-Lapse Live-Cell Imaging
HeLa cells grown on coverglass-bottom chamber slides (Lab Tek) were fixed
with ice-cold methanol for 3 min on ice. For Figures 5A and 6H, CalA (50 nM;
Sigma) was added for 15 min and PurvA (30 mM) for 2 min. The fixed cells were
permeabilized with 0.5% Triton X-100 and exposed to Tris-buffered saline
containing 0.1% Triton X-100 and 2% BSA (AbDil). Images including time-
lapse live-cell analysis (Figures 3A–3G, 5D–5H, and 6J) were acquired with
the 3D-SIM mode using a Super Resolution Microscope (Nikon) (Kitagawa
et al., 2013). For FRAP analysis (Figures 3A–3D and 5E–5H), HeLa cells stably
expressing either GFP-a-tubulin or GFP-histone H2B were transfected with
expression vectors encoding indicated siRNA-resistant mCherry-MKlp2
together with MKlp2 siRNA for 6 hr using Turbofect transfection reagent.
The cells were subsequently treated with either STLC (2.5 mM) or Noco for
16 hr before imaging. The cells were first imaged at l = 543 to visualize
mCherry-MKlp2 fluorescence and l = 488 nm to visualize GFP-a-tubulin or
GFP-histone H2B. A selected area of the cell was photobleached with the
l = 543 and l = 488 laser lines, and FRAP was measured as the increase in
mCherry-MKlp2 and GFP-a-tubulin fluorescence after photobleaching in the
selected area. The data were normalized to the first prebleached image and
corrected for fluorescence loss during recovery by adding back the normalized
fluorescence lost from an unbleached region.
Protein Purification, MBP Pull-Down, ITC, Microtubule Binding, and
Bundling Assays In Vitro
Expression and purification steps for recombinant proteins are described in
Supplemental Experimental Procedures. For the MBP pull-down assay (Fig-
ure 2B), MBP-MKlp2 was loaded onto Amylose beads for 30 min at 4C in
the presence of Buffer B (80 mM PIPES [pH 7.0], 2 mM MgCl2, and 0.5 mM
EGTA) containing 1 mM DTT. The beads were washed with Buffer B and
then incubated overnight at 4C with 6xHis-MKlp21–510. The beads were
washed with Buffer B and analyzed by SDS-PAGE and silver staining (Pierce).
For ITC assay, theN-terminalmotor domain (20 mM)was kept in the cell and the
C-terminal tail (300 mM) was kept in the syringe and in a VP-ITC microcalorim-
eter (Microcal). For each injection, 10 ml of the C-terminal tail was injected into
the cell, and the heat exchange was recorded accordingly. The dissociation
constants of the N-terminal motor domain to the C-terminal tail were deter-
mined using the least-squares method, and the binding isotherm was fitted
using Origin v7.0 (Microcal) assuming a sequential binding model. For the
microtubule binding and sedimentation assays, 1mgofMBP-MKlp2710–890 pro-
teins was supplemented with the indicated amount of KCl and taxol-stabilized
microtubules (BK029; Cytoskeleton) and ultracentrifuged at 100,000 3 g for
30 min at 25C. The resulting supernatant (S) and pellet (P) fractions were
then analyzed by silver staining. For the microtubule bundling assay,
rhodamine-labeled tubulin proteins (TL590M; Cytoskeleton) were reconsti-
tuted to 4 mg/ml with Buffer B containing 1 mM guanosine triphosphate and
10 mM paclitaxel. 0.25 mg of full-length MKlp2 diluted in Buffer B was included
with 4 mg of rhodamine labeled tubulin for 30 min at 25C in a total volume of
20 ml Buffer B containing 10 mM paclitaxel and analyzed after incubation under
a microscope (Nikon Eclipse Ti-E) using a 633 oil-immersion lens. Where indi-
cated, in vitro kinase assaywas performed using 0.1 mg of purified active Cdk1/
cyclin B1 (Millipore) according to the manufacturer’s instructions.
Sucrose Gradient Sedimentation and Fractionation
For Figure 2D, 2 mg of expression vectors encoding the indicated mCherry-
MKlp2 construct was transfected into HeLa cells. At 24 hr after transfection,
the cells were lysed in 200 ml buffer (80 mM PIPES [pH 7.0], 2 mM MgCl2,
0.5 mM EGTA, and 0.1% Triton X-100) containing 1 mM DTT and Complete
Mini and sonicated. The lysates were loaded on top of 11 ml of linear 15%–
35% sucrose density gradient in PE buffer (10 mM PIPES [pH 7.2] and 1 mM178 Cell Reports 7, 166–179, April 10, 2014 ª2014 The AuthorsEDTA) containing 0.1% Triton X-100 and ultracentrifuged in a swinging bucket
SW 41 rotor (Beckman) at 37,500 rpm for 16 hr at 4Cwith an acceleration and
deceleration profile of 7. Fractions were removed from the top. For Figures 2E
and 2F, either Noco-arrested or subsequently released HeLa cells were lysed
in a low salt buffer (80 mM PIPES [pH 7.0], 50 mM NaCl, 2 mMMgCl2, 0.5 mM
EGTA and 0.1% Triton X-100) for 5 min and centrifuged at 13,000 rpm for
15 min. Pellets were resuspended in a high salt buffer containing NaCl
(250mM) for 5min and centrifuged at 13,000 rpm for 15min at 4C. For Figures
4C and 4D, purified MKlp2 from Sf9 insect cells were diluted (final 50 mg/ml) in
80 mM PIPES (pH 7.0), 2 mM MgCl2, 0.5 mM EGTA, 0.1 mM ATP, 1 mM DTT,
and the indicated final concentration of NaCl and incubated for 30min at 25C.
For Figure 4C, samples were centrifuged at 10,0003 g for 30 min at 25C and
the total and supernatant fractions were analyzed. For Figure 4D, samples
were subjected to linear 15%–35% sucrose density gradient sedimentation
at 37,500 rpm for 16 hr at 25C. Malate dehydrogenase (4.3 S), catalase
(11.3 S), and thyroglobulin (19.3 S) (Sigma) were used as standards.
Yeast Two-Hybrid Analysis
For Figures 6D and 6F, MKlp2 cDNA was cloned into the pBTM116 vector as
the bait and the cDNA of INCENP were cloned into the pGAD vector as prey.
Interactions were evaluated by colony growth on Trp, Leu, and His dropout
plates, and a b-galactosidase assay was used for validation.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and five movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.02.034.
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